Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
D

Failure to Limit and Document PRN Psychotropic Medication Use

Carroll, Iowa Survey Completed on 06-24-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to comply with federal regulations regarding the use of PRN (as needed) psychotropic medications, specifically antipsychotics and antianxiety drugs, for a resident with multiple complex medical conditions, including Alzheimer's disease, anxiety disorder, and depression. The clinical record review revealed that PRN antipsychotic medications such as Haloperidol and Zyprexa were ordered and administered for periods exceeding the 14-day federal limit without documented physician assessments or clinical rationales for the extended use. Orders for these medications were repeatedly renewed for 30 days or longer, and pharmacy consulting reports consistently recommended reassessment and adherence to the 14-day limitation, but these recommendations were not followed with appropriate documentation or evaluation by the prescribing physician or practitioner. Additionally, the facility failed to document behavioral symptoms or the use of nonpharmacological interventions prior to administering PRN antianxiety medications, such as Ativan, as required by both facility policy and federal regulation. The medication administration records showed frequent use of these medications over several months, yet there was a lack of corresponding documentation of behaviors or attempts at alternative interventions before medication was given. The Director of Nursing confirmed that staff were expected to document behaviors and nonpharmacological interventions prior to administering PRN psychotropic medications, but this was not consistently done. The facility's own policy required that PRN orders for psychotropic medications be limited to 14 days unless a clinical rationale for extension was documented, and that nonpharmacological approaches be attempted first. Despite this, the clinical records lacked evidence of physician assessments, clinical rationales for extended PRN use, and documentation of behavioral monitoring or nonpharmacological interventions. These failures were observed for one resident reviewed for unnecessary medications, in a facility with a census of 47 residents.

An unhandled error has occurred. Reload 🗙